Search

Your search keyword '"Alegre sancho, Juan Jose"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Alegre sancho, Juan Jose" Remove constraint Author: "Alegre sancho, Juan Jose"
89 results on '"Alegre sancho, Juan Jose"'

Search Results

3. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

4. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

5. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

6. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

7. Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

8. Desarrollo de una aplicación para teléfonos móviles (app) basada en la colaboración Sociedad Española de Reumatología/Sociedad Española de Medicina de Familia y Comunitaria para derivación de enfermedades autoinmunes sistémicas

9. Eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad sintéticos en la artritis reumatoide: revisión sistemática de la literatura

12. Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

13. The complex HLA-E-nonapeptide in Behçet disease

14. Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort

15. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

16. Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

17. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

18. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

19. Mapping and predicting mortality from systemic sclerosis

22. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

25. Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort.

32. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database.

33. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

34. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

38. Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

39. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

40. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

43. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach

44. Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci

45. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

48. Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study

Catalog

Books, media, physical & digital resources